Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
biotech
clinical trials
fda
life sciences
medicine
national blog main
america
billy dunn
biogen
biotech ipos
boston
boston blog main
boston top stories
chronic pain
dhpsp
drug prices
drug pricing
dyne therapeutics
europe
europe top stories
evrysdi
future
gene therapy
genentech
health
ionis pharmaceuticals
khosla ventures
machinelearning
metacrine
ml
myotonic dystrophy type 1
national
national top stories
new york
new york top stories
nonalcoholic steatohepatitis
novartis
nusinersen
pain
physical therapy
What
muscular
4
×
disorders
company
drug
million
new
raised
therapy
ago
approved
atrophy
based
billion
brings
costs
daily
developing
dyne
dyne’s
enable
europe
evrysdi
fda
financing
founded
friday
gait
genetic
green
health
healthcare
home
identify
intended
ipo
khosla
lights
liquid
market
medicine
Language
unset
Current search:
muscular
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@DrSeeboth
3 years ago
This #technology would probably also enable us to identify neurological and muscular gait disorders. #medicine #future #ML #wearables #DHPSP #MachineLearning https://twitter.com/dhpsp/status/1288670220366811138
@techcrunch.com
5 years ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures